Acetarsol in the management of mesalazine refractory ulcerative proctitis: a tertiary-level care experience
(2018)
Journal Article
© 2018 Wolters Kluwer Health, Inc. All rights reserved. Background Mesalazine-refractory ulcerative proctitis is common, with a significant proportion of the patients requiring escalation to immunomodulators or biological therapy. Three small prelimi... Read More about Acetarsol in the management of mesalazine refractory ulcerative proctitis: a tertiary-level care experience.